SCHEMBL2904567

SCHEMBL2904567

CC1CCCC(N)(C(=O)O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.50
CYP1A2 P05177 4/20 0.50
CYP2C19 P33261 3/20 0.50
GRM2 Q14416 2/20 0.50
GRM3 Q14832 2/20 0.50
ALOX15 P16050 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
GRM8 O00222 2/20 0.50
GRM6 O15303 2/20 0.50
ARG1 P05089 1/20 0.50
LMNA P02545 1/20 0.50
GRM5 P41594 1/20 0.50
MTOR P42345 1/20 0.50
GRM1 Q13255 1/20 0.50
PLCB1 Q9NQ66 1/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26923345 1.00 GRM4 (0.50) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL26923301 1.00 GRM4 (0.50) GRM4CYP1A2CYP2C19GRM2GRM3
Hydrochloric Acid SCHEMBL25393736 0.98 ARG1 (0.49) GRM4CYP1A2CYP2C19GRM2GRM3
Hydrochloric Acid SCHEMBL26923446 0.98 ARG1 (0.49) GRM4CYP1A2CYP2C19GRM2GRM3
Hydrochloric Acid SCHEMBL26925051 0.98 ARG1 (0.49) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL31415483 0.94 GRM4 (0.48) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL31415421 0.94 GRM4 (0.48) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL2898361 0.88 GRM4 (0.59) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL31415502 0.84 GRM4 (0.46) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL31415320 0.84 GRM4 (0.46) GRM4CYP1A2CYP2C19GRM2GRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486722-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2025-01-08 EP disclosed
CN-119137101-A Compounds, compositions, and methods 尼科治疗有限公司 2024-12-13 CN disclosed
WO-2023168298-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-09-07 WO disclosed
US-8269046-B2 Cyclic bisamides useful in formulating inks for phase-change printing ARIZONA CHEMICAL COMPANY, LLC (US) 2012-09-18 US disclosed
US-8138119-B2 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids BAYER CROPSCIENCE AG (DE) 2012-03-20 US disclosed
EP-1631633-B1 CYCLIC BISAMIDES USEFUL IN FORMULATING INKS FOR PHASE-CHANGE PRINTING ARIZONA CHEM (US) 2010-08-11 EP disclosed
US-20100064933-A1 Cyclic Bisamides Useful in Formulating Inks for Phase-Change Printing ARIZONA CHEMICAL COMPANY LLC 2010-03-18 US disclosed
US-20090215624-A1 Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids BAYER CROPSCIENCE AG (DE) 2009-08-27 US disclosed
US-20060128992-A1 Cyclic bisamides useful in formulating inks for phase-change printing ARIZONA CHEMICAL COMPANY 2006-06-15 US disclosed
EP-1631633-A2 CYCLIC BISAMIDES USEFUL IN FORMULATING INKS FOR PHASE-CHANGE PRINTING Arizona Chemical Company (US) 2006-03-08 EP disclosed
US-6960248-B2 Cyclic bisamides useful in formulating inks for phase-change printing ARIZONA CHEMICAL COMPANY (US) 2005-11-01 US disclosed
WO-2004106442-A2 CYCLIC BISAMIDES USEFUL IN FORMULATING INKS FOR PHASE-CHANGE PRINTING ARIZONA CHEMICAL COMPANY (US) 2004-12-09 WO disclosed
US-20040231555-A1 Cyclic bisamides useful in formulating inks for phase-change printing ARIZONA CHEMICAL COMPANY 2004-11-25 US disclosed
US-5994274-A Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides BAYER AKTIENGESELLSCHAFT (DE) 1999-11-30 US disclosed
US-5116872-A Fungicides CIBA-GEIGY CORPORATION (US) 1992-05-26 US disclosed
EP-0439426-A1 Microbicidal agents CIBA-GEIGY AG (CH) 1991-07-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215624-A1 Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids DDT, TBCD, TBCA GRM4 396/4885CYP1A2 629/4885CYP2C19 478/4885
US-20060128992-A1 Cyclic bisamides useful in formulating inks for phase-change printing FHIT, DDC, MNAT1 GRM4 1563/4885CYP1A2 253/4885CYP2C19 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.